Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum.
about
Human malarial disease: a consequence of inflammatory cytokine releaseThrombopoietin as biomarker and mediator of cardiovascular damage in critical diseasesNovel targets for interleukin 18 binding proteinMarked elevations in N-terminal brain natriuretic peptide levels in septic shockClinical review: Myocardial depression in sepsis and septic shockSepsis-induced myocardial dysfunction: pathophysiology and managementCardiac Troponins in Dogs and CatsA review of sepsis-induced cardiomyopathyMyocardial Dysfunction and Shock after Cardiac ArrestTargeting interleukin-1 in heart diseaseOverexpression of interleukin-18 aggravates cardiac fibrosis and diastolic dysfunction in fructose-fed ratsLipopolysaccharide improves cardiomyocyte survival and function after serum deprivationElevated cardiac troponin I in sepsis and septic shock: no evidence for thrombus associated myocardial necrosisSeptic cardiomyopathy - A not yet discovered cardiomyopathy?Altered interleukin-1 receptor antagonist and interleukin-18 mRNA expression in myocardial tissues of patients with dilatated cardiomyopathy.Characterization of human septic sera induced gene expression modulation in human myocytes.NOD2-mediated suppression of CD55 on neutrophils enhances C5a generation during polymicrobial sepsis.Can Vaccinations Improve Heart Failure Outcomes?: Contemporary Data and Future Directions.Caspase inhibition prevents cardiac dysfunction and heart apoptosis in a rat model of sepsis.The association between pneumococcal pneumonia and acute cardiac events.Myocardial dysfunction in sepsis: a large, unsolved puzzleCardiac Troponin Release is Associated with Biomarkers of Inflammation and Ventricular Dilatation During Critical Illness.Deeper understanding of mechanisms contributing to sepsis-induced myocardial dysfunction.Lipopolysaccharides induced inflammatory responses and electrophysiological dysfunctions in human-induced pluripotent stem cell derived cardiomyocytesUpdate on meningococcal disease with emphasis on pathogenesis and clinical managementRoles of tumor necrosis factor alpha (TNF-alpha) and the p55 TNF receptor in CD1d induction and coxsackievirus B3-induced myocarditis.Management of the critically ill patient with severe sepsis.Postinfarct intramyocardial injection of mesenchymal stem cells pretreated with TGF-alpha improves acute myocardial function.Aging and animal models of systemic insult: trauma, burn, and sepsis.Bench to bedside: tumor necrosis factor-alpha: from inflammation to resuscitation.Hypoxia-inducible factor 2alpha regulates macrophage function in mouse models of acute and tumor inflammationEffect of glucose-insulin-potassium infusion on mortality in critical care settings: a systematic review and meta-analysis.Interleukin-1β reduces L-type Ca2+ current through protein kinase Cϵ activation in mouse heart.Cardiac function in Vietnamese patients with different dengue severity grades.Severe postpartum sepsis with prolonged myocardial dysfunction: a case report.Enhanced monocyte chemoattractant protein-1 production in aging mice exaggerates cardiac depression during endotoxemiaTLR2 stimulation induces cardiac inflammation but not cardiac depression in vivo.Inhibition of caspase 1 reduces human myocardial ischemic dysfunction via inhibition of IL-18 and IL-1betaThe role of statins in prevention and treatment of community acquired pneumonia: a systematic review and meta-analysis.Modulation of the triggering receptor expressed on the myeloid cell type 1 pathway in murine septic shock
P2860
Q21034098-1B1DA6BF-4947-4B70-9508-2D5FE4E91410Q21296645-CBCDAA89-8CE2-40DB-AD34-DDAB401A1D78Q24292449-8692B958-ECB3-48B4-B8C5-8BC1CDEEB5A5Q24800988-5E907163-31B1-466B-98CE-D4023B0836D3Q24807147-F2182075-B924-4967-B747-764341BAB3BEQ26751572-3002BF2D-8A5E-4B3A-8A8A-057F9897AAF3Q26774969-C1962B09-8A27-43AF-8FAB-FFB68F5E3E5EQ26777219-D27CFFF4-D0B5-467A-8D58-27D3323D43BAQ26784080-D3ED9F56-A335-48D0-B59F-92BE17CB79F6Q27009347-509D9920-3C86-4F8F-B346-28AAD0CB449BQ28571405-3498FC82-4DFF-4C41-80A0-238231E5F7DEQ28576932-4F8E127E-7AA0-497D-BFC8-790976D5DDE5Q28749111-6D9F2D8C-1545-49CF-937E-5FC20B8A5B05Q30319484-32A54915-4C76-483F-B27F-BD5E90AE3D76Q30319742-31A1EC73-EAA3-448D-8A6B-DD120BE9B40FQ30487504-D390D605-5FE6-42C0-B4AE-32559D69DA3FQ31117454-5BF68619-00BF-4B4A-B60E-7977991BA9A9Q31159585-8BA9F467-AA81-4947-980D-1A21BA2766E8Q32033049-A2F0B994-8579-4754-8EC2-637E26F6D870Q33288215-BFDB834C-81EE-4A4B-B149-B69096F84992Q33353302-78F4FE85-945E-44E8-9185-A255AAE32442Q33643868-58E9ACAE-46EB-4DBB-9AAF-091DBD377A60Q33751030-074D6688-AC4B-4D20-AF63-E190E3F48C79Q33774097-8ECDE3A0-38DC-4E4A-894F-ED6B11AF764AQ33812435-A39A1268-9A3B-4F39-B52A-76642B632571Q33833868-60DFDAD9-54BE-4BF0-887B-2F62A55C2E40Q33840109-02005A15-733E-41AE-8DAB-470B6505FF9EQ33994997-9AD60410-D58A-4205-8E56-FAF88FF0D0B5Q34010902-361B10D0-7B45-494F-BCFC-6FCE6CA0392EQ34013294-17A72A4C-99BC-44BD-BC3C-09B9F1FD791AQ34028645-216E876F-7041-4115-B049-9E70F9C3BF54Q34054903-33030970-0963-4CA0-B5A9-12850E099EBDQ34070335-D4E26CF1-6FE5-480D-975E-875C7B493CEFQ34074313-4B1EBFAA-9109-42A7-A12C-922FDE7DA961Q34221236-684D10DC-287B-4210-A449-1257DF3C029AQ34233617-549AF5A8-3AA6-425D-AE34-8D9C977F67BBQ34255776-B5EEE9FC-9F23-4DF1-9989-75A8888F75A9Q34501732-0038927C-BA1C-43E0-8281-37D09B94549DQ34562123-1A1958B0-6AD1-4793-9FD2-96080E1C0E8FQ34602001-FEC7EB5F-3145-453E-97BC-16A2303B040F
P2860
Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Tumor necrosis factor alpha an ...... d by human septic shock serum.
@en
type
label
Tumor necrosis factor alpha an ...... d by human septic shock serum.
@en
prefLabel
Tumor necrosis factor alpha an ...... d by human septic shock serum.
@en
P2093
P2860
P356
P1476
Tumor necrosis factor alpha an ...... d by human septic shock serum.
@en
P2093
P2860
P304
P356
10.1084/JEM.183.3.949
P407
P577
1996-03-01T00:00:00Z